Semier Scientific (QB) Stock Price - SMLR

42.50
0.00 (0.0%)
42.50
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
Semier Scientific Inc (QB) SMLR OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 42.50 41.00 43.20 42.50 42.50 16:15:00
Bid Price Ask Price Spread Spread % News
42.05 43.00 0.95 2.21% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
66 12,633 $ 42.2198 $ 533,363 18,961 30.00 - 57.84
Last Trade Time Type Quantity Stock Price Currency
15:54:29 5 $ 42.99 USD

Semier Scientific (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 277.70M 6.53M 3.07M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
4.20k $ - 0.00% - -

more financials information »

Semier Scientific (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SMLR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week42.1045.0041.0042.7112,8130.400.95%
1 Month43.1045.0039.3141.4416,581-0.60-1.39%
3 Months40.76646.9130.0039.2218,4581.734.25%
6 Months43.0057.8430.0044.2916,498-0.50-1.16%
1 Year42.5157.8430.0044.1615,332-0.01-0.02%
3 Years3.1457.842.7731.7817,59339.361,253.5%
5 Years1.57757.841.2829.0316,20540.922,594.99%

Semier Scientific (QB) Description

Semler Scientific, Inc. is a company providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Our mission is to develop, manufacture and market innovative proprietary products and services that assist our customers in evaluating and treating chronic diseases. In 2011, we began commercializing our first patented and U.S. Food and Drug Administration, or FDA, cleared product, which measured arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease, or PAD. In March 2015, we received FDA 510(k) clearance for the next generation version of our product, QuantaFlo, which we began commercializing in August 2015. We believe our products and services position us to provide valuable information to our customer base, which in turn permits them to better guide patient care.


Your Recent History
USOTC
SMLR
Semier Sci..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.